SOPHiA GENETICS SA
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-79.0M | $-62.5M | $-79.0M | $-87.4M | $-73.7M | $-39.3M | $-33.8M |
| Depreciation & Amortization | — | — | — | — | — | — | — |
| Depreciation | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — |
| Stock-Based Compensation | $93.7M | $86.1M | $90.2M | $84.4M | $70.7M | $45.1M | $31.4M |
| Net Cash from Operating Activities | $-35.9M | $-44.5M | $-53.2M | $-70.1M | $-57.9M | $-31.7M | $-31.7M |
| Investing Activities | |||||||
| Capital Expenditures | $574.0K | $244.0K | $1.5M | $4.1M | $2.7M | $450.0K | $1.4M |
| Business Acquisitions | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-8.7M | $-4.8M | $13.0M | $42.0M | $-56.9M | $-24.3M | $-3.0M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $30.2M | $9.9M | $-2.8M | $-1.6M | $237.8M | $107.0M | $-1.0M |
| Net Change in Cash | — | — | — | — | — | — | — |
| Free Cash Flow | $-36.5M | $-44.8M | $-54.7M | $-74.2M | $-60.6M | $-32.2M | $-33.0M |